Allisa Clemens

Statistics

Publications

Citations

261

H-Index

Active since

2023

Affiliations

Denali Therapeutics (United States)(Current)

Biogen (United States)

Ionis Pharmaceuticals (United States)

University of Minnesota

Allisa Clemens is an author at Denali Therapeutics (United States) specializing in blood-brain barrier penetration, blood-brain barrier delivery, and brain targeted delivery.

Publications per year

2023–2025

Publications

Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier

Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim et al. · Science Translational Medicine · 2024 · 119 citations

Pharmacy, Neuroscience, Pharmacology +17

Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution

Nathalie Khoury, Michelle E. Pizzo, Claire B. Discenza et al. · Nature Communications · 2025 · 50 citations · Full text

Pharmacy, Neuroscience, Pharmaceutics +16

Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA

Michelle E. Pizzo, Edward D. Plowey, Nathalie Khoury et al. · Science · 2025 · 44 citations

Pharmacy, Neuroscience, Pharmaceutics +17

Targeting Transferrin Receptor to Transport Antisense Oligonucleotides Across the Blood-Brain Barrier

Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 24 citations · Full text

Pharmacy, Neuroscience, Pharmaceutics +17

Engineering anti-amyloid antibodies with transferrin receptor targeting improves brain biodistribution and mitigates ARIA

Michelle E. Pizzo, Edward D. Plowey, Nathalie Khoury et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 13 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 6